{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:50:10Z","timestamp":1770745810806,"version":"3.49.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,28]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The risk of fragility fractures is high in kidney transplant recipients, and steroids are reportedly a major cause. Other drugs known to induce fragility fractures have been studied in the general population but not in kidney transplant recipients. Here, we investigated the association between exposure over time to drugs that can injure bone (namely vitamin K antagonists, insulin, loop diuretics, proton pump inhibitors, opioids, selective serotonin reuptake inhibitors, antiepileptics and benzodiazepines) and incident fractures and changes over time in T-scores in this population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 613 consecutive kidney transplant recipients were included between 2006 and 2019. Drug exposures and incident fractures during the study period were comprehensively documented, and dual-energy X-ray absorptiometry was performed regularly. The data were analyzed using Cox proportional hazards models with time-dependent covariates and linear mixed models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Incident fractures occurred in 63 patients, giving a fracture incidence of 16.9 per 1000 person-years. Exposures to loop diuretics [hazard ratio (95% confidence interval) 2.11 (1.17\u20133.79)] and opioids [5.94 (2.14\u201316.52)] were associated with incident fractures. Exposure to loop diuretics was associated with a decrease over time in the T-score for the lumbar spine (P\u00a0=\u00a0.022) and for the wrist (P\u00a0=\u00a0.028).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study suggests that the exposure to loop diuretics and opioids increases the risk of fracture in kidney transplant recipients.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ckj\/sfac265","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T15:49:51Z","timestamp":1670428191000},"page":"571-584","source":"Crossref","is-referenced-by-count":5,"title":["Drugs associated with incident fragility fractures in kidney transplant recipients"],"prefix":"10.1093","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9466-7110","authenticated-orcid":false,"given":"Benjamin","family":"Batteux","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, Amiens University Medical Center , Amiens , France"},{"name":"MP3CV Laboratory, EA7517, Jules Verne University of Picardie , Amiens , France"},{"name":"Department of Rheumatology , Saint-Quentin Medical Center, Saint-Quentin , France"},{"name":"Amiens-Picardie University Medical Center RECIF (R\u00e9seau d\u2019Epid\u00e9miologie Clinique International Francophone), , Amiens , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alban","family":"Nowak","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Amiens University Medical Center , Amiens , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"S\u00e9journ\u00e9","sequence":"additional","affiliation":[{"name":"Department of Rheumatology , Saint-Quentin Medical Center, Saint-Quentin , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9mence","family":"Penet","sequence":"additional","affiliation":[{"name":"Department of Rheumatology , Saint-Quentin Medical Center, Saint-Quentin , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamel","family":"Masmoudi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Amiens University Medical Center , Amiens , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Brazier","sequence":"additional","affiliation":[{"name":"MP3CV Laboratory, EA7517, Jules Verne University of Picardie , Amiens , France"},{"name":"Department of Nephrology Internal Medicine Dialysis Transplantation, Amiens University Medical Center , Amiens , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sol\u00e8ne M","family":"Laville","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Amiens University Medical Center , Amiens , France"},{"name":"MP3CV Laboratory, EA7517, Jules Verne University of Picardie , Amiens , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0186-4797","authenticated-orcid":false,"given":"Youssef","family":"Bennis","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Amiens University Medical Center , Amiens , France"},{"name":"MP3CV Laboratory, EA7517, Jules Verne University of Picardie , Amiens , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Gras-Champel","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Amiens University Medical Center , Amiens , France"},{"name":"MP3CV Laboratory, EA7517, Jules Verne University of Picardie , Amiens , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Choukroun","sequence":"additional","affiliation":[{"name":"MP3CV Laboratory, EA7517, Jules Verne University of Picardie , Amiens , France"},{"name":"Department of Nephrology Internal Medicine Dialysis Transplantation, Amiens University Medical Center , Amiens , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5384-9006","authenticated-orcid":false,"given":"Sophie","family":"Liabeuf","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Amiens University Medical Center , Amiens , France"},{"name":"MP3CV Laboratory, EA7517, Jules Verne University of Picardie , Amiens , France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF01622200","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group","volume":"4","author":"Kanis","year":"1994","journal-title":"Osteoporos Int"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2147\/TCRM.S138000","article-title":"A comprehensive overview on osteoporosis and its risk factors","volume":"14","author":"Pouresmaeili","year":"2018","journal-title":"Ther Clin Risk Manage"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"116137","DOI":"10.1016\/j.bone.2021.116137","article-title":"Associations between osteoporosis and drug exposure: a post-marketing study of the World Health Organization pharmacovigilance database (VigiBase\u00ae)","volume":"153","author":"Batteux","year":"2021","journal-title":"Bone"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00223-020-00786-0","article-title":"Traditional and non-traditional risk factors for osteoporosis in CKD","volume":"108","author":"J\u00f8rgensen","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000072552","article-title":"Pathogenesis and treatment of renal osteodystrophy","volume":"21","author":"Slatopolsky","year":"2003","journal-title":"Blood Purif"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/TP.0b013e31828eead8","article-title":"Fracture risk in kidney transplant recipients: a systematic review","volume":"95","author":"Naylor","year":"2013","journal-title":"Transplantation"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1600-6143.2011.03872.x","article-title":"Reduced fracture risk with early corticosteroid withdrawal after kidney transplant","volume":"12","author":"Nikkel","year":"2012","journal-title":"Am J Transplant"},{"key":"2023022812303644800_","article-title":"Early steroid withdrawal has a positive effect on bone in kidney transplant recipients: a propensity score study with inverse probability-of-treatment weighting","author":"Batteux","journal-title":"Ther"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s001980070078","article-title":"Recognition of vertebral fracture in a clinical setting","volume":"11","author":"Gehlbach","year":"2000","journal-title":"Osteoporos Int"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis","volume":"9","author":"Kanis","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0962280206074463","article-title":"Multiple imputation of discrete and continuous data by fully conditional specification","volume":"16","author":"van Buuren","year":"2007","journal-title":"Stat Methods Med Res"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/sim.2580","article-title":"A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study","volume":"26","author":"Austin","year":"2007","journal-title":"Stat Med"},{"key":"2023022812303644800_","first-page":"32","article-title":"Management of adynamic bone disease in chronic kidney disease: a brief review","volume":"5","author":"Sista","year":"2016","journal-title":"J Clin Transl Endocrinol"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa011807","article-title":"Intravenous zoledronic acid in postmenopausal women with low bone mineral density","volume":"346","author":"Reid","year":"2002","journal-title":"N Engl J Med"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ekir.2020.10.011","article-title":"Evaluation of changes over time in the drug burden and medication regimen complexity in ESRD patients before and after renal transplantation","volume":"6","author":"Marienne","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archinte.168.7.735","article-title":"Loop diuretic use and increased rates of hip bone loss in older men: the osteoporotic fractures in men study","volume":"168","author":"Lim","year":"2008","journal-title":"Arch Intern Med"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/jbmr.5650080604","article-title":"Determinants of bone mineral density and risk factors for osteoporosis in healthy elderly women","volume":"8","author":"Ooms","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2796.2005.01585.x","article-title":"Fracture risk in patients treated with loop diuretics","volume":"259","author":"Rejnmark","year":"2006","journal-title":"J Intern Med"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/HJH.0000000000002245","article-title":"Antihypertensive drug classes and the risk of hip fracture: results from the Swedish primary care cardiovascular database","volume":"38","author":"Bokrantz","year":"2020","journal-title":"J Hypertens"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2362.2003.01103.x","article-title":"Dose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: a randomized, double-blinded Latin-square multiple cross-over study in postmenopausal osteopenic women","volume":"33","author":"Rejnmark","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"371.e1","DOI":"10.1016\/j.jamda.2017.12.013","article-title":"Fall-risk-increasing drugs: a systematic review and meta-analysis: I. Cardiovascular drugs","volume":"19","author":"de Vries","year":"2018","journal-title":"J Am Med Dir Assoc"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"115475","DOI":"10.1016\/j.bone.2020.115475","article-title":"The impact of thiazide diuretics on bone mineral density and the trabecular bone score: the Rotterdam Study","volume":"138","author":"van der Burgh","year":"2020","journal-title":"Bone"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"100737","DOI":"10.1016\/j.bonr.2020.100737","article-title":"Effects of bendroflumethiazide on bone mineral density; results from the BONATHIAD randomized double-blind placebo-controlled cohort study","volume":"13","author":"Emmanuel","year":"2020","journal-title":"Bone Rep"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3389\/fphar.2019.01364","article-title":"Thiazide diuretics and the incidence of osteoporotic fracture: a systematic review and meta-analysis of cohort studies","volume":"10","author":"Wang","year":"2019","journal-title":"Front Pharmacol"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archinte.166.2.241","article-title":"Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2","volume":"166","author":"Gage","year":"2006","journal-title":"Arch Intern Med"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1001\/archinte.159.15.1750","article-title":"Long-term use of oral anticoagulants and the risk of fracture","volume":"159","author":"Caraballo","year":"1999","journal-title":"Arch Intern Med"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00075197-200111000-00003","article-title":"Effects of vitamin K on calcium and bone metabolism","volume":"4","author":"Zittermann","year":"2001","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-128-10-199805150-00006","article-title":"Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group","volume":"128","author":"Jamal","year":"1998","journal-title":"Ann Intern Med"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1532-5415.2008.01786.x","article-title":"Single-point assessment of warfarin use and risk of osteoporosis in elderly men","volume":"56","author":"Woo","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1756-185X.2009.01395.x","article-title":"Reduced bone density in patients on long-term warfarin","volume":"12","author":"Rezaieyazdi","year":"2009","journal-title":"Int J Rheum Dis"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"713187","DOI":"10.3389\/fcvm.2021.713187","article-title":"Association of direct oral anticoagulants vs. vitamin K antagonists with fractures in atrial fibrillation patients: a systematic review and meta-analysis","volume":"8","author":"Wu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fphar.2018.00348","article-title":"Non-vitamin K antagonist oral anticoagulants vs. warfarin at risk of fractures: a systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Gu","year":"2018","journal-title":"Front Pharmacol"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2796.2006.01667.x","article-title":"Fracture risk associated with the use of morphine and opiates","volume":"260","author":"Vestergaard","year":"2006","journal-title":"J Intern Med"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archinte.163.8.949","article-title":"Central nervous system active medications and risk for fractures in older women","volume":"163","author":"Ensrud","year":"2003","journal-title":"Arch Intern Med"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/j.pain.0000000000001412","article-title":"Incident opioid use and risk of hip fracture among persons with Alzheimer disease: a nationwide matched cohort study","volume":"160","author":"Taipale","year":"2019","journal-title":"Pain"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.01.038","article-title":"Testosterone suppression in opioid users: a systematic review and meta-analysis","volume":"149","author":"Bawor","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1038\/s41598-022-07178-4","article-title":"Characteristics of fracture in patients who firstly starts kidney replacement therapy in Korea: a retrospective population-based study","volume":"12","author":"Kim","year":"2022","journal-title":"Sci Rep"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1047-2797(01)00226-5","article-title":"Hospitalizations for fractures after renal transplantation in the United States","volume":"11","author":"Abbott","year":"2001","journal-title":"Ann Epidemiol"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.kint.2018.12.024","article-title":"Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients","volume":"95","author":"Evenepoel","year":"2019","journal-title":"Kidney Int"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/TP.0b013e318176b40f","article-title":"Bisphosphonates and bone fractures in long-term kidney transplant recipients","volume":"86","author":"Conley","year":"2008","journal-title":"Transplantation"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00198-015-3465-7","article-title":"Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials","volume":"27","author":"Wang","year":"2016","journal-title":"Osteoporos Int"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/ctr.12792","article-title":"Outcomes of bisphosphonate therapy in kidney transplant recipients: a systematic review and meta-analysis","volume":"30","author":"Toth-Manikowski","year":"2016","journal-title":"Clin Transplant"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/nu14020323","article-title":"Bone mineral density changes in long-term kidney transplant recipients: a real-life cohort study of native vitamin D supplementation","volume":"14","author":"Battaglia","year":"2022","journal-title":"Nutrients"},{"key":"2023022812303644800_","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2215\/CJN.03410321","article-title":"Bone and mineral disease in kidney transplant recipients","volume":"17","author":"Khairallah","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023022812303644800_","first-page":"1282","article-title":"Bone disease after kidney transplantation","volume-title":"Clin J Am Soc Nephrol","author":"Bouquegneau","year":"2016"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfac265\/49099617\/sfac265.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/16\/3\/571\/49352008\/sfac265.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/16\/3\/571\/49352008\/sfac265.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T11:21:59Z","timestamp":1678965719000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/16\/3\/571\/6886554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,12,9]]},"published-print":{"date-parts":[[2023,2,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfac265","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3]]},"published":{"date-parts":[[2022,12,9]]}}}